PTCT
PTC Therapeutics Inc
Price:  
38.85 
USD
Volume:  
1,357,523.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT Relative Valuation

-657.0%
Upside

As of 2024-05-22, the Relative Valuation of PTC Therapeutics Inc (PTCT) is (216.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.85 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -657.0%.

The range of the Relative Valuation is (214.49) - (217.21) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.4x - 33.5x 29.5x
Forward P/E multiples 26.5x - 28.8x 27.8x
Fair Price (214.49) - (217.21) (216.38)
Upside -652.1% - -659.1% -657.0%
38.85 USD
Stock Price
(216.38) USD
Fair Price

PTCT Relative Valuation - Historical P/E Data

Date P/E
2024-05-21 -5.14
2024-05-20 -5.31
2024-05-17 -4.38
2024-05-16 -4.51
2024-05-15 -4.46
2024-05-14 -4.13
2024-05-13 -4.20
2024-05-10 -4.27
2024-05-09 -4.11
2024-05-08 -4.12
2024-05-07 -4.21
2024-05-06 -4.36
2024-05-03 -4.37
2024-05-02 -4.45
2024-05-01 -4.52
2024-04-30 -4.26
2024-04-29 -4.26
2024-04-26 -3.78
2024-04-25 -3.38
2024-04-24 -3.34
2024-04-23 -3.36
2024-04-22 -3.44
2024-04-19 -3.35
2024-04-18 -3.27
2024-04-17 -3.33
2024-04-16 -3.35
2024-04-15 -3.40
2024-04-12 -3.50
2024-04-11 -3.63
2024-04-10 -3.56
2024-04-09 -3.65
2024-04-08 -3.56
2024-04-05 -3.58
2024-04-04 -3.68
2024-04-03 -3.84
2024-04-02 -3.76
2024-04-01 -3.79
2024-03-28 -3.85
2024-03-27 -3.90
2024-03-26 -3.70
2024-03-25 -3.82
2024-03-22 -3.85
2024-03-21 -3.99
2024-03-20 -3.91
2024-03-19 -4.03
2024-03-18 -3.84
2024-03-15 -3.91
2024-03-14 -3.83
2024-03-13 -4.08
2024-03-12 -4.20